Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04125537 · ClinicalTrials.gov registry record

Pathways Project: Kidney Supportive Care

A clinical trial, sponsored by George Washington University.

Completed
Registry status
476
Enrollment target

NCT04125537: Completed study, sponsored by George Washington University.

NCT04125537 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 476 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04125537 has completed, sponsored by George Washington University.

COMPLETED
Registry status
476 participants
Enrollment target

Study Summary

The Pathways Collaborative is the first attempt to implement supportive (palliative) kidney care at multiple sites in the United States. While supportive kidney care is growing in other countries, notably Canada, Australia, and Great Britain, it is not yet known how to integrate it into the unique nephrology environment in the United States. In Phase 1 of Pathways (completed), we developed an evidence-based change packet of 14 best practices for integrating supportive care practices into the continuum of care for patients with end stage kidney disease (ESKD). In Phase 2 (described in this application), we will conduct a learning collaborative to help up to 15 dialysis and CKD centers implement these best practices. The learning collaborative is based on the IHI Collaborative Model for Achieving Breakthrough Improvement. This model is a tested systematic approach to quality improvement designed to help organizations close the gap between current and future practice based on evidence-based best practices. The Pathways Project faculty will work with up to 15 change teams at dialysis centers to create a system to identify seriously ill patients with kidney disease; conduct conversations with them so that their values, preferences, and goals for current and future medical treatment are known and respected; assess and address patients' physical, psychological and spiritual needs; and coordinate care throughout the healthcare system so patients receive only the care they want in settings in which they wish to be.

Primary Outcome

The primary patient reported outcome for the intervention will be patient reported quality of end of life communication, as measured by the Engelberg quality of communication questionnaire, a subscale on end of life communication.

Interventions

  • BEHAVIORAL IHI Breakthrough Collaborative Model

Trial Details

FieldValue
Enrollment Target 476 participants
Start Date 2018-11-01
Est. Completion 2020-10-31
George Washington University

133 total trials

What the finished NCT04125537 record still lists

NCT04125537 is an observational study that tracks outcomes without assigning an intervention. The registered 476 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which IHI Breakthrough Collaborative Model is the first listed.

NCT04125537 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04125537 about?

NCT04125537 is a clinical study titled "Pathways Project: Kidney Supportive Care". The Pathways Collaborative is the first attempt to implement supportive (palliative) kidney care at multiple sites in the United States. While supportive kidney care is growing in other countries, notably Canada, Australia, and Great Britain, it is not yet known how to integrate it into the unique n...

What is the current status of trial NCT04125537?

This trial is currently completed. The enrollment target is 476 participants. The study started on 2018-11-01. Estimated completion is 2020-10-31.

What interventions are being tested in trial NCT04125537?

The interventions under investigation include: IHI Breakthrough Collaborative Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT04125537?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06754046 · 476 participants · NA

    BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)

  • NCT03911700 · 477 participants · NA

    Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

  • NCT06997497 · 477 participants · Phase 3

    A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • NCT01788839 · 475 participants

    Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04125537, the US trial registry maintained by the National Library of Medicine. NCT04125537 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.